Skip to content

HUMA

Humacyte, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.39
−8.09%
Ask drillr

Leverage

Debt / equity
2.12x
Net debt / equity
-0.44x
Debt / assets
0.48x
Debt / EBITDA
-0.84x
Net debt / EBITDA
0.17x

Liquidity & coverage

Current ratio
6.21x
Quick ratio
5.74x
Cash ratio
5.35x
Interest coverage
-10.80x
EBITDA / interest
-7.69x
Working capital
$77.8M

Cash & dividend

FCF / debt
-1.47x
Cash flow / debt
-1.47x
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026